Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
26 hedge funds and large institutions have $15.1M invested in Biolase, Inc. in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
8% more funds holding
Funds holding: 24 → 26 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $15.8M → $15.1M (-$699K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$39.3K |
| 3 |
TFO
Tarbox Family Office
Newport Beach,
California
|
+$33.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.2K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$5.62K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$89.8K |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$17K |
| 3 |
ECM
Evergreen Capital Management
Bellevue,
Washington
|
-$7K |
| 4 |
VF
Virtu Financial
New York
|
-$7K |
| 5 |
BlackRock
New York
|
-$5.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WS
26
Wedbush Securities
Los Angeles,
California
| $4K | – | – | – |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
FDCDDQ
28
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1 | – | – | – |
|
|
PGCM
29
Prescott Group Capital Management
Tulsa,
Oklahoma
| – | -$17K | -3 | Closed |
|
|
ECM
30
Evergreen Capital Management
Bellevue,
Washington
| – | -$7K | -1 | Closed |
|
|
VF
31
Virtu Financial
New York
| – | -$7K | -1 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | -$1K | – | – |
|
BIOL Hedge Fund Activity: Q1 2018 in Review
26 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2018, worth a combined $15.1M — down 4.4% from $15.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BIOL positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $73K. The largest seller was Trellus Management Company, cutting an estimated $89.8K.
- 26 institutional investors held Biolase, Inc. (BIOL) as of Q1 2018, up from 24 in Q4 2017.
- Funds reported $15.1M of Biolase, Inc. stock for Q1 2018, down 4.4% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q1 2018 and 3 closed out, a net change of +2 holders.
- The largest Biolase, Inc. buyer in Q1 2018 was Vanguard Group, an estimated $73K added.
- The largest Biolase, Inc. seller in Q1 2018 was Trellus Management Company, an estimated $89.8K sold.
Based on aggregated 13F filings for Q1 2018.